Eagle Pharmaceuticals Inc (EGRX)

Currency in USD
0.250
0.000(0.00%)
Closed·
EGRX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.2500.341
52 wk Range
0.1003.870
Key Statistics
Prev. Close
0.25
Open
0.341
Day's Range
0.25-0.341
52 wk Range
0.1-3.87
Volume
331
Average Volume (3m)
5.95K
1-Year Change
-72.2222%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
EGRX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Eagle Pharmaceuticals Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Eagle Pharmaceuticals Inc Company Profile

Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on manufacturing, developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company’s product portfolio offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin’s lymphoma. It also produces PEMFEXY, a ready-to-dilute liquid form of pemetrexed injection for non-small cell lung cancer and mesothelioma. The company has license and collaboration agreements with Combioxin, SA for the development and commercialization rights to CAL02, an anti-toxin agent in Phase 2 development for the treatment of severe pneumonia in combination with traditional antibacterial drugs. It has a strategic collaboration with Tyme Technologies, Inc. for the development of SM-88 to treat cancer. Eagle Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Woodcliff Lake, New Jersey.

Employees
134

Compare EGRX to Peers and Sector

Metrics to compare
EGRX
Peers
Sector
Relationship
P/E Ratio
0.0x5.3x−0.5x
PEG Ratio
0.000.120.00
Price/Book
0.0x3.6x2.6x
Price / LTM Sales
0.0x5.1x3.3x
Upside (Analyst Target)
0.0%302.7%45.0%
Fair Value Upside
Unlock14.5%5.1%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Nov 28, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / 54.09M
EPS Revisions
Last 90 days

EGRX Income Statement

FAQ

What Is the Eagle Pharm (EGRX) Stock Price Today?

The Eagle Pharm stock price today is 0.250

What Stock Exchange Does Eagle Pharm Trade On?

Eagle Pharm is listed and trades on the OTC Markets.

What Is the Stock Symbol for Eagle Pharm?

The stock symbol for Eagle Pharm is "EGRX."

What Is the Eagle Pharm Market Cap?

As of today, Eagle Pharm market cap is 4.44M.

What Is Eagle Pharm's Earnings Per Share (TTM)?

The Eagle Pharm EPS (TTM) is 0.91.

When Is the Next Eagle Pharm Earnings Date?

Eagle Pharm will release its next earnings report on Mar 09, 2026.

From a Technical Analysis Perspective, Is EGRX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Eagle Pharm Stock Split?

Eagle Pharm has split 0 times.

How Many Employees Does Eagle Pharm Have?

Eagle Pharm has 134 employees.

What is the current trading status of Eagle Pharm (EGRX)?

As of Feb 10, 2026, Eagle Pharm (EGRX) is trading at a price of 0.250, with a previous close of 0.250. The stock has fluctuated within a day range of 0.250 to 0.341, while its 52-week range spans from 0.100 to 3.870.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.